tradingkey.logo
tradingkey.logo
Search

DarioHealth Corp

DRIO
Add to Watchlist
7.585USD
+0.255+3.48%
Close 08-14 16:00ETQuotes delayed by 15 min
55.36MMarket Cap
LossP/E TTM

More Details of DarioHealth Corp Company

DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.

DarioHealth Corp Profile

Ticker SymbolDRIO
Company nameDarioHealth Corp
IPO dateMar 08, 2013
CEORaphael (Erez)
Number of employees196
Security typeOrdinary Share
Fiscal year-endMar 08
Address322 W 57Th St. #33B
CityNEW YORK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code10019
Phone16466654667
Websitehttps://shop.mydario.com/
Ticker SymbolDRIO
IPO dateMar 08, 2013
CEORaphael (Erez)

Company Executives of DarioHealth Corp

Name
Name/Position
Position
Shareholding
Change
Mr. Erez Raphael
Mr. Erez Raphael
Chief Executive Officer, Director
Chief Executive Officer, Director
97.43K
--
Mr. Erez Raphael
Mr. Erez Raphael
Chief Executive Officer, Director
Chief Executive Officer, Director
97.43K
--
Mr. Dennis Matheis, CPA
Mr. Dennis Matheis, CPA
Independent Director
Independent Director
23.03K
+62.67%
Mr. Dennis Matheis, CPA
Mr. Dennis Matheis, CPA
Independent Director
Independent Director
23.03K
+62.67%
Mr. Yoav Shaked
Mr. Yoav Shaked
Independent Chairman of the Board
Independent Chairman of the Board
13.66K
--
Mr. Yoav Shaked
Mr. Yoav Shaked
Independent Chairman of the Board
Independent Chairman of the Board
13.66K
--
Ms. Hila Karah
Ms. Hila Karah
Independent Director
Independent Director
10.96K
--
Ms. Hila Karah
Ms. Hila Karah
Independent Director
Independent Director
10.96K
--
Mrs. Chen Franco-Yehuda
Mrs. Chen Franco-Yehuda
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.33K
-259.97%
Mrs. Chen Franco-Yehuda
Mrs. Chen Franco-Yehuda
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.33K
-259.97%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Erez Raphael
Mr. Erez Raphael
Chief Executive Officer, Director
Chief Executive Officer, Director
97.43K
--
Mr. Erez Raphael
Mr. Erez Raphael
Chief Executive Officer, Director
Chief Executive Officer, Director
97.43K
--
Mr. Dennis Matheis, CPA
Mr. Dennis Matheis, CPA
Independent Director
Independent Director
23.03K
+62.67%
Mr. Dennis Matheis, CPA
Mr. Dennis Matheis, CPA
Independent Director
Independent Director
23.03K
+62.67%
Mr. Yoav Shaked
Mr. Yoav Shaked
Independent Chairman of the Board
Independent Chairman of the Board
13.66K
--
Mr. Yoav Shaked
Mr. Yoav Shaked
Independent Chairman of the Board
Independent Chairman of the Board
13.66K
--

FAQs

Who are the top five shareholders of DarioHealth Corp?

The top five shareholders of DarioHealth Corp are: Mr. Erez Raphael

How many institutions hold shares of DarioHealth Corp (DRIO)?

As of 2026Q1, 74 institutions hold shares of DarioHealth Corp, with a combined market value of approximately 782.90K, accounting for 10.72% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -221463.00.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.